Evidence map›Paper›PMID 31614630›Full record

ReviewNutrients2019

Curcumin, Gut Microbiota, and Neuroprotection.

Francesco Di Meo, Sabrina Margarucci, Umberto Galderisi, Stefania Crispi, Gianfranco Peluso

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 2 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 2 syntheses or guidelines pooled it, 206 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Curcumin enhances the oral bioavailability of testosterone by inhibiting its intestinal metabolism.Drug metabolism and disposition: the biological fate of chemicals · 2025
    Trial
  4. Trial
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Impact of curcumin on gut microbiome.World journal of experimental medicine · 2025
    Review
  19. Review
  20. Review

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Francesco Di MeoInstitute of Biosciences and BioResources-UOS Naples CNR, Via P. Castellino, 80100 Naples, Italy. francesco.dimeo.90@gmail.com.
Sabrina MargarucciInstitute of Research on Terrestrial Ecosystems, 05010 Porano TR, Italy. sabrina.margarucci@cnr.it.
Umberto GalderisiDepartment of Experimental Medicine, University of Campania "Luigi Vanvitelli", Via Santa Maria di Costantinopoli, 80100 Naples, Italy. umberto.galderisi@unicampania.it.
Stefania CrispiInstitute of Biosciences and BioResources-UOS Naples CNR, Via P. Castellino, 80100 Naples, Italy. stefania.crispi@cnr.it.
Gianfranco PelusoInstitute of Research on Terrestrial Ecosystems, 05010 Porano TR, Italy. gianfranco.peluso@cnr.it.
Institute of Biosciences and Bioresources · ITInstitute of Ecosystem Study · ITUniversity of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Curcumin, a nontoxic, naturally occurring polyphenol, has been recently proposed for the management of neurodegenerative and neurological diseases. However, a discrepancy exists between the well-documented pharmacological activities that curcumin seems to possess in vivo and its poor aqueous solubility, bioavailability, and pharmacokinetic profiles that should limit any therapeutic effect. Thus, it is possible that curcumin could exert direct regulative effects primarily in the gastrointestinal tract, where high concentrations of curcumin are present after oral administration. Indeed, a new working hypothesis that could explain the neuroprotective role of curcumin despite its limited availability is that curcumin acts indirectly on the central nervous system by influencing the "microbiota-gut-brain axis", a complex bidirectional system in which the microbiome and its composition represent a factor which preserves and determines brain "health". Interestingly, curcumin and its metabolites might provide benefit by restoring dysbiosis of gut microbiome. Conversely, curcumin is subject to bacterial enzymatic modifications, forming pharmacologically more active metabolites than curcumin. These mutual interactions allow to keep proper individual physiologic functions and play a key role in neuroprotection.

Indexed as

CurcuminGastrointestinal MicrobiomeHumansNeuroprotectionCurcuminbioactivitycurcumingut microbiomametabolismneuroprotectionpolyphenols

Identifiers

PMID31614630
PMCPMC6835970
OpenAlexW2979405293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.